Stock AXPH ALEXANDRIA CO. FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES
Add to a list
To use this feature you must be a member
Log inSign up

Alexandria Co. For Pharmaceuticals & Chemical Industries Stock

Equities

AXPH

EGS38341C011

Pharmaceuticals

End-of-day quote Egyptian Exchange
Other stock markets
 18:00:00 2024-05-21 EDT 		5-day change 1st Jan Change
215.1 EGP 0.00% Intraday chart for Alexandria Co. For Pharmaceuticals & Chemical Industries 0.00% +20.65%
2023 Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
2022 Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022 CI

Financials

Sales 2022 1.22B 26.04M 35.62M Sales 2023 1.48B 31.76M 43.44M Capitalization 691M 14.78M 20.22M
Net income 2022 129M 2.76M 3.78M Net income 2023 126M 2.7M 3.69M EV / Sales 2022 0.32 x
Net cash position 2022 145M 3.09M 4.23M Net cash position 2023 78.48M 1.68M 2.3M EV / Sales 2023 0.41 x
P/E ratio 2022
4.1 x
P/E ratio 2023
5.47 x
Employees -
Yield 2022 *
-
Yield 2023
9.41%
Free-Float 19.62%
More Fundamentals * Assessed data

Chart Alexandria Co. For Pharmaceuticals & Chemical Industries

Dynamic Chart

Latest news about Alexandria Co. For Pharmaceuticals & Chemical Industries

Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2022 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2021 CI
VAlexandria Pharmaceuticals Announces Consolidated Earnings Results for the Six Months Ended December 31, 2020 CI
Alexandria Co. for Pharmaceuticals and Chemical Industries Recommends Cash Dividend for Fiscal Year 2019/2020 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Announces Earnings Results for the Year Ended on 30 June 2020 CI
Alexandria Pharmaceuticals Announces Earnings Results for the Year Ended June 30, 2019 CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2018 CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Reviewed Earnings Results for the Period Ended December 31, 2018 CI
Alexandria Pharmaceuticals Reports Earnings Results for the Three Months Ended September 30, 2018 CI
Alexandria Pharmaceuticals Declares Cash Dividend, Payable on October 28, 2018 CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended June 30, 2018 CI
Alexandria Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2018 CI
Alexandria Pharmaceuticals Reports Earnings Results for the Half Year Ended December 31, 2017 CI
More news

Press releases Alexandria Co. For Pharmaceuticals & Chemical Industries

Alexandria For Pharmaceuticals & Chemical Industries : Pharmaceuticals (AXPH.CA) Reports 6 Months Results PU
More press releases

Quotes and Performance

1 month-3.05%
3 months-11.02%
6 months+37.61%
Current year+20.65%
More quotes

Highs and lows

1 week
207.25
Extreme 207.25
216.94
1 month
192.16
Extreme 192.16
222.00
Current year
178.50
Extreme 178.5
249.98
1 year
120.00
Extreme 120
249.98
3 years
85.00
Extreme 85
249.98
5 years
85.00
Extreme 85
249.98
10 years
41.85
Extreme 41.85
249.98
More quotes

Managers and Directors - Alexandria Co. For Pharmaceuticals & Chemical Industries

Managers TitleAgeSince
Abla Youssef Abdullah CEO
 Chief Executive Officer - -
Mohammed Noman Salamah DFI
 Director of Finance/CFO - -
Ahmed Fuad ADM
 Chief Administrative Officer - -
Members of the board TitleAgeSince
Mustafa Abdel Monem El-Hayawan CHM
 Chairman - -
Sherif Salah Mohammed Tahoun BRD
 Director/Board Member - -
Abla Youssef Abdullah CEO
 Chief Executive Officer - -
More insiders

Quotes

Date Price Change Volume
24-05-22 215.1 0.00% 843
24-05-21 215.1 0.00% 147
24-05-20 215.1 0.00% 172
24-05-19 215.1 0.00% 1,972
24-05-16 215.1 0.00% 1,038

End-of-day quote Egyptian Exchange, May 21, 2024

More quotes

Company Profile

Alexandria Co. for Pharmaceuticals & Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, dermatological, cardiovascular, allergic, epileptic, gastrointestinal diseases, etc. The group also provides veterinary and medical products (adhesive tape, gauze compresses, gloves, traction kits, etc.).
Sector
Pharmaceuticals
More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ALEXANDRIA CO. FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES Stock Alexandria Co. For Pharmaceuticals & Chemical Industries
+20.65% 23.05M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+37.74% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.22% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.07% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.25% 331B
ABBVIE INC. Stock AbbVie Inc.
+2.99% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.60% 244B
NOVARTIS AG Stock Novartis AG
+9.77% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-5.15% 208B
AMGEN INC. Stock Amgen Inc.
+7.43% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AXPH Stock